PCE Home Study
Embracing New Treatment Options in the Management of Migraine Headache
Release Date: August 31, 2020
Expiration Date: August 30, 2021
CE/CME Credit Hours: 1.00
Pharmacology Credit Hours: 1.00
Begin »
program overview
Program Description
Migraine is a chronic disease that remains underdiagnosed, and many patients suffer from its debilitating effects for years before receiving appropriate treatment. In this case-based discussion, an expert in migraine explains how to make the differential diagnosis, select appropriate evidence-based treatment, including established and emerging options, and adapt the regimen to the patient’s unique situation.
Format
Interactive video lecture
Learning Objectives
After completing this activity, participants should be better able to:
- Apply current diagnostic criteria for differential diagnosis of migraine to increase early recognition and treatment
- Employ current migraine guideline recommendations and management strategies to establish improved patient treatment plans
- Identify the appropriate use of established and emerging treatment options for migraine and related monitoring and safety options
Target Audience
NPs and PAs
Faculty
Nada Hindiyeh, MD
- Clinical Assistant Professor
- Department of Neurology and Neurological Surgery
- Director
- Clinical Research in Headache
- Stanford University
- Palo Alto, California
Mary Knudtson, DNSc, NP, FAAN
- Professor of Clinical Nursing
- University of California, Irvine
- Irvine, California
- Nurse Practitioner
- JumpstartMD
- Medical Reserve Corps County of Santa Cruz
- Santa Cruz, California
DETAILS
Joint Accreditation Statement
In support of improving patient care, Practicing Clinicians Exchange is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
ANCC Credit Designation
Nursing contact hours: 1.00, which includes 1.00 hour of pharmacology credit
CNE course advisor: Mary Knudtson, DNSc, NP, FAAN, University of California, Irvine, Irvine, California
AAPA Credit Designation
Practicing Clinicians Exchange has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credit. Approval is valid until August 30, 2021. PAs should only claim credit commensurate with the extent of their participation.
PA planner: Lawrence Herman, MPA, PA-C, Palantir Healthcare LLC, Boiling Springs, South Carolina
IPCE Credit Designation
This activity was planned by and for the healthcare team, and learners will receive 1.00 Interprofessional Continuing Education (IPCE) credit for learning and change.
This activity was developed from a series of programs cosupported by educational grants from AbbVie Inc.; Alcon Vision, LLC; Amgen; Genentech, a member of the Roche Group; Novartis Pharmaceuticals Corporation; Sanofi Genzyme and Regeneron Pharmaceuticals; and Teva Pharmaceuticals.
This activity is supported by an educational grant from Teva Pharmaceuticals.
The opinions or views expressed in this CE/CME activity do not necessarily reflect the opinions or recommendations of Practicing Clinicians Exchange or any educational supporter.
All faculty and planners participating in continuing education activities sponsored by Practicing Clinicians Exchange are required to disclose to the audience any relevant support or substantial relationships with providers of commercial products and/or devices discussed in this activity and/or with any commercial supporters of the activity. In addition, all faculty are required to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in this activity. The faculty and planning committee have been advised that this activity must be free from commercial bias, and based upon all the available scientifically rigorous data from research that conforms to accepted standards of experimental design, data collection, and analysis.
Mr Herman: consultant/speakers bureau: Novo Nordisk.
Dr Hindiyeh: advisory board: Alder/Lundbeck, Amgen; advisory board/speakers bureau: Eli Lilly.
Dr Knudtson: has no relevant relationships to disclose.
None of the members of the Planning Committee or PCE staff have any relevant relationships to disclose, except Mr Herman as noted above.
Participants wishing to earn CE/CME credit must:
- View the content in its entirety
- Relate the content material to the learning objectives
- Complete the post-test and evaluation form
Successful completion of the post-test is required to earn CE/CME credit. Successful completion is defined as a cumulative score of at least 70%.
The estimated time to complete this activity is 1.00 hours.
Release date: August 31, 2020
Expiration date: August 30, 2021
For Practicing Clinicians Exchange general information, contact pce@practicingclinicians.com.
© 2020 Practicing Clinicians Exchange. All Rights Reserved. 97120CPCE-7D